Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient. 2004

Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron

UI MeSH Term Description Entries
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017211 Treatment Failure A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. Failure, Treatment,Failures, Treatment,Treatment Failures
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D061466 Lopinavir An HIV protease inhibitor used in a fixed-dose combination with RITONAVIR. It is also an inhibitor of CYTOCHROME P-450 CYP3A. A-157378.0,ABT 378,ABT-378,N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide,A 157378.0,A157378.0,ABT378
D019438 Ritonavir An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A. ABT 538,ABT-538,Norvir,ABT538

Related Publications

Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
January 2002, The Annals of pharmacotherapy,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
December 2000, Research initiative, treatment action : RITA,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
January 2004, HIV clinical trials,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
June 2009, AIDS (London, England),
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
October 2014, International journal of STD & AIDS,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
March 2004, AIDS (London, England),
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
January 2002, The Journal of the Association of Nurses in AIDS Care : JANAC,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
March 2004, TreatmentUpdate,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
January 2008, TreatmentUpdate,
Francesca Conradie, and Ian Sanne, and Willem Venter, and Joseph Eron
January 2002, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
Copied contents to your clipboard!